Zymeworks Inc. (ZYME) stock
ZYMENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30667% above fair value
$26.04+0.20 (+0.77%)
Close on Nov 18, 2026Market cap $1.85BP/E –Yield –
Zymeworks shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Zymeworks's shares outstanding was 73M at Jun 30, 2026. For fiscal 2025 it was 75M, down 0.6% from the year before. The highest annual figure on record is 76M in fiscal 2024.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 75M | -0.6% |
| FY2024 | Dec 31, 2024 | 76M | +10.2% |
| FY2023 | Dec 31, 2023 | 69M | +5.5% |
| FY2022 | Dec 31, 2022 | 65M | +25.2% |
| FY2021 | Dec 31, 2021 | 52M | +3.5% |
| FY2020 | Dec 31, 2020 | 50M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 73M | -5.7% |
| Q1 FY2026 | Mar 31, 2026 | 75M | -0.7% |
| Q4 FY2025 | Dec 31, 2025 | 75M | +0.8% |
| Q3 FY2025 | Sep 30, 2025 | 76M | -0.5% |
| Q2 FY2025 | Jun 30, 2025 | 77M | +1.3% |
| Q1 FY2025 | Mar 31, 2025 | 75M | -1.3% |
| Q4 FY2024 | Dec 31, 2024 | 75M | +5.5% |
| Q3 FY2024 | Sep 30, 2024 | 76M | +7.9% |
| Q2 FY2024 | Jun 30, 2024 | 76M | +13.5% |
| Q1 FY2024 | Mar 31, 2024 | 76M | +14.2% |
| Q4 FY2023 | Dec 31, 2023 | 71M | +6.1% |
| Q3 FY2023 | Sep 30, 2023 | 71M | +6.2% |
| Q2 FY2023 | Jun 30, 2023 | 67M | +1.4% |
| Q1 FY2023 | Mar 31, 2023 | 67M | +8.7% |
| Q4 FY2022 | Dec 31, 2022 | 67M | +28.0% |
| Q3 FY2022 | Sep 30, 2022 | 66M | +27.3% |
| Q2 FY2022 | Jun 30, 2022 | 66M | – |
| Q1 FY2022 | Mar 31, 2022 | 61M | – |
| Q4 FY2021 | Dec 31, 2021 | 52M | – |
| Q3 FY2021 | Sep 30, 2021 | 52M | – |
See a number that looks wrong?